Hütter, Gero : Chemoresistenzassoziierte Veränderungen der Proteinexpression bei Kolon-, Mamma-, Magen-, Pankreaskarzinom und Fibrosarkom mit Hilfe der hochauflösenden zweidimensionalen Elektrophorese im immobilisierten pH-Gradienten


[Aguilar-Bryan 1995] Aguilar-Bryan, L., Nichols, C.G., Wechsler, S.W. et al.: "Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. " Science . 1995: 268(5209): 423-426.

[Anderson 1978] Anderson, N.G., Anderson, N.L .: "Analytical techniques for cell fractions. XXI. Two-dimensional analysis of serum and tissue proteins: multiple isoelectric focusing." Anal. Biochem . 1978: 85(2): 331-340 u. 341-354.

[Anderson 1982] Anderson, N.G., Anderson, L .: "The Human Protein Index." Clin. Chem . 1982: 28(4 Pt 2): 739-748.

[Antonarakis 1998] Antonarakis, S.E., Aelst, L .: "Mind the GAP, Rho, Rab and GDI." Nature Genetics 1998: 19: 106-108.

[Arrick 1984] Arrick, B.A., Nathan, C.F .: "Glutathione metabolism as a determinat of therapeutic efficacy: A rewiew." Cancer Res . 1984: 44: 4224-4232.

[Aubel 1984] Aubel-Sadron, G., Londos-Gagliardi, D .: "Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review" . Biochimie 1984: 66(5): 333-352.

[Baas 1990] Baas F., Jongsma A.P., Broxterman H.J. et al.: "Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. " Cancer Res . 1990: 50(17): 5392-5398.

[Babson 1981] Babson, J.R., Abell, N.S., Reed, D.J ".: Protective role of the glutathione redox cycle against Adriamycin-mediated toxicity in isolated hepatocytes" . Biochem. Pharmacol . 1981: 30: 2299-2304.

[Baker 1997] Baker, A., Payne, C.M. et al.: "Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis." Cancer Res. 1997: 57: 5162-5167.

[Bakos 1996] Bakos, E., Hegedus, T., Hollo, Z. et al.: "Membrane topology and glycosylation of the human multidrug resistance-associated protein. " J. Biol. Chem. 1996: 271(21): 12322-12326.

[Barrand 1994] Barrand, M.A., Heppell-Parton, A.C., Wright, K.A. et al.: "A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene." J. Natl. Cancer Inst. 1994: 86(2): 110-117.

[Bass 1993] Bass, N.M .: "Cellular binding proteins of fatty acids and retinoids: similar or specialized functions?" Mol. Cell. Biochem. 1993: 123: 1991-202.

[Batist 1986] Batist, G., Tulpule, A., Sinha, B.K. et al.: "Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells" . J. Biol. Chem. 1986: 261: 15544.

[Bell 1985] Bell, D.R., Gerlach, J.H. et al.: "Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multdrug resistance." J. Clin. Oncol. 1985: 3: 311-315.

[Bender 1975] Bender, R.A .: "Membrane transport of methotrexate in human neoplastic cells." Cancer Chemoth. Rep . 1975: 6: 73-82.

[Bertino 1980] Bertino, J.R : "Approches to drug selectivity in cancer therapy on the basis of differences betwen membrans of normal vs. neoplastic cells." Adv. Pathobiol . 1980: 7: 377-386.

[Bjellqvist 1982] Bjellqvist, B., Ek, K., Righetti, P.G. et al.: "Isoelectric focusing in immobilized pH gradients: principle, methodology and some applications" . J. Biochem. Biophys. Methods 1982: 6(4): 317-339.

[Blose 1985] Blose, S.H., Hamburger, S.H .: "Computer-analyzed high resolution two-dimensional gel electrophoresis: a new window for protein research." Bio Techniques 1985: May/June: 232-236.

[Bordow 1995] Bordow, S.B., Haber, M., Madafiglio, J. et al".: Expression of the multidrug resitance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma." Cancer Res. 1994: 54: 5036-5040.

[Brownawell 1996] Bronawell, A.M., Creutz, C.E .: "Calcium-dependent binding of the plasma protein Apollipoprotein A-1 to two members of the annexin family" . Biochemistry 1996: 35: 6839-6845.

[Borst 1991] Borst, P. : "Genetic mechanisms of drug resistance. A review." Acta. Oncol . 1991: 30(1): 87-105.

[Bourhis 1989] Bourhis, J., Benard, J., Hartmann, O. et al.: "Correlation of mdr1 gene expression with chemotherapy in neuroblastoma." J. Natl. Cancer Inst. 1989: 81(18): 1401-1405.

[Bradley 1988] Bradley, G., Juranka, P.F., Ling, V. : "Mechanism of multidrug resistance." Biochim. Biophys. Acta 1988: 948(1): 87-128.

[Brock 1995] Brock, I., Hipfner, D.R., Nielsen, B.S. et al.: "Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etopoiside)-selcted H69 small cell lung cancer cells." Cancer Res. 1995: 55: 459-462.

[Broxterman 1988] Broxterman, H.J., Pinedo, H.M., Kuiper, C.K. et al".: Induction by verampamil of a rapid increase in ATP consumption in multidrug-resistant tumor cells. " FASEB J 1988: 2: 2278-2282.

[Broxterman 1995] Broxterman, H.J., Giaccone, G., Lankelma, J. : "Multidrug resistance proteins and other drug transport-related resistance to natural product agents" . Curr. Opin. Oncol . 1995: 7(6): 532-540.

[Buller 1987] Buller, A.L., Clapper, M.L., Tew, K.D. : "Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines." Mol. Pharmacol. 1987: 31(6): 575-578.

[Carlier 1997] Carlier, M.F., Laurent, V. et al".: Actin depolymerizing factor (ADF/Cofilin) enhances the Rate of filament turnover: Implication in actin-based motility." J. Cell. Biolg. 1997: 136(6): 1307-1323.

[Chan 1990] Chan, H.S., Thorner, P.S., Haddad, G., Ling, V. : "Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. " J. Clin. Oncol. 1990: 8(4):689-704.

[Chiari 1989a] Chiari, M., Casale, E., Santaniello, E.; Rhighetti, P.G. : "Synthesis of buffers for generating immobilized pH gradients. I: Acidic acrylamido buffers" . Appl. Theor. Electroph. 1989: 1: 99-102.

[Chiari 1989b] Chiari, M., Casale, E., Santaniello, E.; Rhighetti, P.G. : "Synthesis of buffers for generating immobilized pH gradients. II: Basic acrylamido buffers." Appl. Theor. Electroph. 1989: 1: 103-107.

[Chin 1992] Chin, K.V., Ueda, K., Pastan, I., Gottesman, M.M. : "Modulation of activity of the promoter of the human MDR1 gene by Ras and p53." Science 1992: 255: 459-462.

[Chong 1994] Chong, L.D. et al.: "The small GTP-binding protein Rho regulates a phosphatidylinostol 4-phosphate 5-kinsae in mammalian cells." Cell 1994: 79: 507-513.

[Chrambach 1973] Chrambach, A., Doerr, P., Finlayson, G.R., Miles, L.E., Sherins, R., Rodbard, D .: "Instability of pH gradients formed by isoelectric focusing in polyacrylamide gel. " Ann. NY Acad.Sci. 1973: 209: 44-64.

[Chuman 1996] E Chuman, Y., Sumizawa, T. et al.: "Expression of the multidrug-resistance-associated protein (MRP) gene in human colorectal, gastric and non-small-cell lung carcinomas." Int. J. Cancer. 1996: 66(2): 274-279.

[Cohen 1978] Cohen, M., Bender, R.A., Donehower, R.C., Myers, C.E., Chabner, B.A. : "Reversibility of high-affinity ninding of methotrexate in L1210 murine leukaemia cells. " Cancer Res. 1978: 38: 866-870.

[Cohen 1995] Cohen, B.E., Lee,G. et al.: "Cyclic 3'-5'-adenosine monophosphate binds to annexin I and regulates calcium-dependent membrane aggregation and ion channel activity." FEBS-Lett. 1995: 377(3): 444-450.

[Cole 1992a] Cole, S.P.C., Bhardwaj, G., Gerlach, J.H. et al".: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line." Science 1992: 258(5088): 1650-1654.

[Cole 1992b] Cole, S.P.C., Pinkoski, M.J. et al".: Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistent small cell lung cancer cell line." Br. J. Cancer 1992: 65(4): 498-502.

[Cole 1993] Cole, S.P.C., Deeley, R.G ".: Multdrug resistance-protein: sequenz correction." Science 1992: 258: 879.

[Cole 1994] Cole, S.P.C., Sparks, K.E., Fraser, K., Loe, D.W., Grant, C. E. et al.: "Pharmacological charakterization of multidrug resistant MRP-transfected human tumor cells." Cancer Res. 1994: 54: 5902-5910.

[Cornwell 1986] Cornwell, M.M., Gottesman, M.M., Pastan, I. : "Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells." J. Biol. Chem. 1986: 261: 7921-7928.

[Cornwell 1987] Cornwell, M.M., Tsudo, T., Gottesman, M.M., Pastan, I. : "ATP-binding properties of P-glycoprotein from multidrug-resistant KB cells." FASEB J. 1987: 1: 51-54.

[Crespi 1986] Crespi, M.D., Ivanier, S.E., Genovese, J., Baldi, A ".: Mitoxantrone affects topoisomerase activities in human breast cancer cells." Biochem. Biophys. Res. Commun. 1986: 136(2): 521-528.

[Dale 1969] Dale, G., Latner, A.L. : "Isoelectric focusing of serum proteins in acrylamide gels followed by electrophoresis. " Clin. Chim. Acta. 1969: 24(1): 61-68.

[Danley 1996] Danley, D.E., Chuang, T.H., Bokoch, G.M ".: Defective Rho GTPase regulation by IL-1 beta-converting enzyme-mediated cleavage of D4 GDP dissociation inhibitor. " J. Immunol. 1996: 157(2): 500-503.

[Dano 1973] Dano, K .: "Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells." Biochim. Biophys. Acta 1973: 323(3): 466-483.

[Dellambra 1995] Dellambra, E., Patrone, M. et al.: "Stratifin, a keratinocyte specific 14-3-3 protein, harbors a pleckstrin homology (PH) domain and enhances protein kinase C activity." J. Cell. Sci. 1995: 108 ( Pt 11): 3569-3579.

[Demple 1985] Demple, B., Sedgwick, B., Robins, P. et al.: "Active site and complete sequence of the suicidal methyltransferase that counters alkylation mutagenesis." Proc. Natl. Acad. Sci USA. 1985: 82(9): 2688-2692.

[Dietel 1987] Dietel, M., Arps, H. et al.: "Establishment of primary cell cultures: experiences with 155 cell strains." Klin. Wochenschr. 1987: 65: 507-512.

[Dietel 1990] Dietel, M., Arps, H., Lage, H., Niendorf, A. : "Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257." Cancer Res. 1990: 50: 6100-6106.

[Dreier 1998] Dreier, R., Schmid, K.W. et al.: "Differential expression of annexin I,II and IV in human tisssues: an immunhistochemical study. Histochem." Cell Biol. 1998: 110: 137-148.

[Dumenco 1989] Dumenco, L.L., Warman, B. et al.: "Increase in nitrosourea resistance in mammalian cells by retrovirally mediated gene transfer of bacterial O6-alkylguanine-DNA alkyltransferase." Cancer Res. 1989: 49: 6044-6051.

[Durr 1983] Durr, F.E., Wallace, R.E. et al.: "Molecular and biochemical pharmacology of mitoxantrone." Cancer Treat. Rev. 1983: 10 Suppl B: 3-11.

[Ecker 1995] Ecker, G., Chiba, P ".: Structure-activity-relationship studies on modulators of the multidrug transporter P-glycoprotein-an overview." Klin. Wochenschr 1995: 107: 681-686.

[Eliopoulos 1995] "Eliopoulos, A.G., Kerr, D.J. et al.: The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and bcl-2. " Oncogene "1995: 11: 1217-1228."

"[" Eijdems 1995] Eijdems, E.W.H.M., De Haas, M., Covo-Martin, J.M. : "Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP amplicon." Int. J. Cancer 1995: 60: 676-684.

[Fan 1994] Fan, D., Poste, G., Seid, C., Earnest, L.E., Bull, T., Clyne, R.K., Fidler, I.J. : "Reversal of multidrug resistance in murine fibrosarcoma cells by thioxanthene flupentixol." Invest. New Drugs 1994: 12(3): 185-195.

[Ferrando 1996] Ferrando, A:A., Velasco, G. et al.: "Cloning and expression analysis of human bleomycin hydrolase, a cysteine proteinase involved in chemotherapy resistance. " Cancer Res. 1996: 56: 1746-1750.

[Flower 1994] Flower, R.J., Rothwell, N.J ".: Lipocortin-1: cellular mechanisms and clinical relevance." Trends Pharmacol. Sci. 1994: 15(3): 71-76.

[Fojo 1987] Fojo, A.T., Ueda, K., Slamon, D.J. : "Expression of a multidrug-resistance gene in human tumors and tissues." Proc. Natl. Acad. Sci. USA 1987: 85: 265-269.

[Friedberg 1985] Friedberg, E.C. : "DNA Repair" . NY 1985.

[Futscher 1994] Futscher, B.W., Abbaszadegan, M.R., Domann, F., Dalton, W.S ".: Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells. " Biochem. Pharmacol. 1994: 47(9): 1601-1606.

[Garrels 1989] Garrels, J.I. : "The QUEST system for quantitative analysis of two-dimensional gels." J. Biol. Chem. 1989: 264: 5269-5282.

[Gasdaska 1994] Gasdaska, P.Y., Oblong, J.E. et al.: "The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors." Biochim. Biophys. Acta. 1994: 1218(3): 292-296.

[Gaveby 1988] Gaveby B.M., Pettersson P., Andrasko J., Ineva-Flygare L. et al.: "Stable storage conditions of immobiline chemicals for isoelectric focusing" . J. Biochem. Biophys. Methods. 1988: 16(2-3): 141-164.

[Gaveby 1988] Gaveby, B.M. et al.: "Stable storage conditions of immobiline chemicals for isoelectric focusing." J. Biochem. Biophys. Methods 1988: 16: 141-164.

[Geier 1994] Geier, A., Hemi, R., Haimsohn, M., Beery, R. et al.: "Epidermal growth factor and insulin-like growth factor-1 protect MDA-231 cells from death induced by Actinomycin D: The involvement of growth factors in drug resistance." In Vitro Cell. Dev. Biol. 1994: 30A: 336-343.

[Gelfi 1984] Gelfi, C., Righetti, P.G. :" Swelling kinetics of immobiline gels for isoelectric focussing." Electrophoresis 1984: 5: 257-262.

[Gelfi 1987] Gelfi, C., Bossi, M.L., Bjellqvist, B., Righetti, P.G. : "Isoelectric focusing in immobilized pH gradients in the pH 10-11 range" . J. Biochem. Biophys. Methods 1987: 15(1): 41-48.

[Gerlach 1986] Gerlach, J.H., Kartner, N., Bell, D.R., Ling, V. : "Multidrug resistance" . Cancer Surv. 1986: 5(1): 25-46.

[Gerlach 1987] Gerlach, J.H., Bell, D.R. et al.: "P-glycoprotein in human sarcoma: evidence for multidrug resistance." J. Clin. Oncol. 1987: 5(9): 1452-1460.

[Glatz 1997] Glatz, J.F.C., Luiken, J.J.F.O. et al.: "Molecular mechanism of cellular uptake and intracellular translocation of fatty acids" . Prostaglandins, Leukotriens and Essential Fatty Acids 1997: 57(1): 3-9.

[Glisson 1987] Glisson, B.S., Ross, W.E. : "DNA topoisomerase II: a primer on the enzyme and its unique role as a multidrug target in cancer chemotherapy. " Pharmacol. Ther. 1987: 32(2): 89-106.

[Goldenberg 1969] Goldenberg, G.J. : "Properties of L5178Y lymphoblasts highly resistant to nitrogen mustard." Ann. NY Acad. Sci. 1969: 163: 936-953

[Goldie 1980] Goldie, J.H., Krystal, G., Hartley, D. et al".: A methotrexate insensitive variant of folate reductase present in two lines of methotrexate-resistant L5178Y cells." Eur. J. Cancer 1980: 16(12): 1539-1546.

[Goldman 1978] Goldman, I.D., Lichtenstein, N.S., Oliverio, V.T. : "Carrier-mediated transport of the folic acid analogue methotrexate in the L1210 leukaemia cell" . J. Biolg. Chem. 1978: 243: 5007-5017.

[Goldstein 1989] Goldstein, L.J., Galski, H., Fojo, A.T., Willingham, M., Lai, S.L., Gazdar, A., Pirker, R. et al".: Expression of a multidrug resistance gene in human cancers." J. Natl. Cancer Inst. 1989: 81(2): 116-124.

[Goldstein 1990] Goldstein, L.J., Fojo, A.T., Ueda, K., Crist, W., Green, A., Brodeur, G., Pastan, I., Gottesman, M.M. : "Expression of the multidrugresistance, MDR1, gene in neuroblastomas." J. Clin. Oncol. 1990: 8(1): 128-136.

[Gomi 1997] Gomi, A., Masuzawa, T., Ishikawa, T., Kuo, M.T ".: Posttranscriptional regulation of MRP/GS-X pump and gamma-glutamylcysteine synthetase expression by 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea and by cycloheximide in human glioma cells. " Biochem. Biophys. Res. Commun. 1997: 239(1): 51-56.

[Gonsalvez 1974] Gonsalvez, M., Blanco, M., Hunter, J., Miko, M., Chanhce, B. : "Effects of anticancer agents on the respiratiom od isolated mitochondria and tumour cells." Eurp. J. of Cancer 1974: 10: 567-574.

[Görg 1988] "Görg, A., Postel, W., Günther, S." : "The current state of two-dimensional electrophoresis with immobilized pH Gradints." Electrophoresis 1988: 9: 531-546.

[Gors 1986] Gros, P., Croop, J., Robinson, I., Varshavsky, A., Hausman, D.E. : "Isolation and characterization of DNA sequences amplified in multidrug resistant hamster cells." Proc. Natl. Acad. Sci. USA 1986: 83: 337-341.

[Grant 1994] Grant, C.E., Valdimarsson, G., Hipfner, D.R. et al".: Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs." Cancer Res. 1994: 54(2): 357-361.

[Grosse 1995] Grosse, R., Zschiesche, W. et al".: Mammary-derived growth inhibitor (MDGI): a new differentiation factor involved in breast cancer progression. Hormones and Growth Factors in Development and Neoplasia" , Fogarty International Conference, June 26-28, 1995: 14.

[Gurtoo 1981] Gurtoo, H.L., Hipkens, J.H., Sharma, S.D. : "Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide." Cancer Res. 1981: 41: 3584-3591.

[Hall 1998] Hall, A. : "Rho GTPases and the actin cytoskeleton. " Science 1998: 279: 509-514.

[Hamada 1988] Hamada, H., Okochi, E., Watanabe, M., Oh-hara, T. et al.: "Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells. " Cancer Res. 1988: 48(24 Pt 1): 7082-7087.

[Harker 1989] Harker, W.G., Slade, D.L., Dalton, W.S., Meltzer, P.S. et al.: "Multidrug resistance in mitoxantrone-selected hl-60 leukemia cells in the absence of p-glycoprotein overexpression." Cancer Res. 1989: 49(16): 4542-4549.

[Harker 1991] Harker, W.G., Slade, D.L. et al.: "Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II beta isoform." Biochemistry 1991: 30(41): 9953-9961.

[Harris 1985] Harris, A.L. : "DNA repair and resistance to chemotherapy." Cancer Surv. 1985: 4: 601-624.

[Hayes 1990] Hayes, J.D., Wolf, C.R. : "Molecular mechanisms of drug resistance." Biochem. J. 1990: 272(2): 281-295.

[Henderson 1984] Henderson, G.B., Zevely, E.M. : "Transport routes utiliezed by L1210 cells for influx and efflux of methotrexate." J. Biolg. Chem. 1984: 254: 1526-1531.

[Hermeking 1997] Hermeking, H., Lengauer, C. et al".: 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. " Mol. Cell. 1997: 1(1): 3-11.

[Herweijer 1990] Herweijer, H., Sonneveld, P., Baas, F., Nooter, K. : "Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine." J. Natl. Cancer Inst. 1990: 82(13): 1133-1140.

[Hill 1979] Hill, B.T., Bailey, B.D., White, J.C., Goldman, I.D. : "Characteristics of transport of 4-amino antifolats ans folate compounds by two cell lines of L5178Y lymphblasts, one with impaired transport of methotrexate." Cancer Res. 1979, 39: 2440-2446.

[Hill 1995] Hill, C.S. et al.: "The Rho family GTPase RhoA, Rac1, and Cdc42Hs regulate transcriptional activation by SRF." Cell 1995: 81: 1159-1170.

[Hirono 1961] Hirono, I. : "Mechanism of natural and aquired resistance to methyl-bis(?-chlorethyl)-amine N-oxide in ascites tumors. " Gann. 1961: 52: 39-48.

[Hohoff 1998] Hohoff, C., Spener, F ".: Fatty acid binding proteins and mammary growth inhibitor. " Fett/Lipid 1998: 100: 252-263.

[Holm 1989] Holm, C., Stearns, T., Botstein, D ".: DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage." Mol. Cell. Biol. 1989: 9: 159-168.

[Horio 1988] Horio, M., Gottesman, M.M., Pastan, I. : "ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells." Proc. Natl. Acad. Sci. USA 1988: 85(10): 3580-3584.

[Ito 1989] Ito, Y., Tanimoto, M. et al.: "Increased P-glycoprotein expression and multidrug-resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial presentation and relapsed stage." Cancer 1989: 63(8): 1534-1538.

[Ito 1997] Ito, K., Suzuki, H., Hirohashi, T., Kume, K., Shimizu, T., Sugiyama, Y. : "Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR." Am. J. Physiol. 1997: 272(1 Pt 1): G16-22.

[Izquierdo 1996a] Izquierdo, M.A., Shoemaker, R..H., Flens, M.J., Scheffer, G.L., Wu, L. et al.: "Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines." Int. J. Cancer 1996: 65(2): 230-237.

[Izquierdo 1996b] Izquierdo, M.A., Scheffer, G.L., Flens, M.J. et al ".: Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. " Am. J. Pathol. 1996: 148(3): 877-887.

[Jansen 1989] Jansen, G., Westerhof, G.R., Kathmann, I., Rademaker, B.C., Rijksen, G., Schornagel, J.H. : "Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance." Cancer Res. 1989: 49: 2455-2459.

[Jedlitschky 1996] Jedlitschky, G., Leier, I., Buchholz, U. et al".: Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump." Cancer Res. 1996: 56(5): 988-994.

[Ji 1997] Ji, H., Liu, Y.E. et al.: "Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing." Cancer Res. 1997: 57(4): 759-764.

[Judson 1992] Judson, I.R ".: Understanding anticancer drug resistance: opportunities for modulation and impact on new drug design." Eur. J. Cancer 1992: 28(1): 285-289.

[Juliano 1976] Juliano, R.L., Ling, V. : "A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants." Biochim. Biophys. Acta 1976: 455(1): 152-162.

[Jungblut 1996] Junglut, P., Thiede, B. et al.: "Resolution power of two-dimensional electrophoresis and idenification of proteins from gels." Electroph. 1996: 17: 839-847.

[Kakehi 1988] Kakehi, Y., Kanamaru, H., Yoshida, O., Ohkubo, H., Nakanishi, S. et al.: "Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance." J. Urol. 1988: 139(4): 862-865.

[Kanamaru 1989] Kanamaru, H., Kakehi, Y., Yoshida, O. et al.: "Mdr1 RNA levels in human renal cell carcinomas correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants." J. Natl. Cancer Inst. 1989: 81(11): 844-849.

[Katzmann 1995] Katzmann, D.J., Hallstrom, T.C., Voet, M., Wysock, W. et al.: "Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin resistance in Saccharomyces cerevisiae" . Mol. Cell. Biol. 1995: 15(12): 6875-6883.

[Kaye 1995] Kaye, S.B ".: Clinical drug resistance: the role of factors other than P-glycoprotein. " Am. J. Med. 1995: 99(6A): 40S-44S.

[Kelley 1988] Kelley, S.L., Basu, A., Teicher, B.A., Hacker, M.P., Hamer, D.H., Lazo, J.S. : "Overexpression of metallothionein confers resistance to anticancer drugs." Science 1988: 241(4874): 1813-1815.

[Kessel 1968] Kessel, D., Botterill, V., Wodinsky, I. : "Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response." Cancer Res. 1968: 28(5): 938-941.

[Kessel 1969] Kessel, D., Hall, T.C., Rosenthall, L.E. : "Uptake and phosphorylation of cytosin arabinoside by normal and leukaemic human blood cells in vitro. " Cancer Res. 1969; 29: 459-463.

[Keyomarsi 1986] Keyomarsi, K., Moran, R.G. : "Folinc acid augmentation of effects of fluoropyrimidines on murin and human leukaemic cells." Cancer Res. 1986: 46: 5229-5253.

[Klose 1975] Klose, J. : "Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals." Humangenetik 1975: 26(3): 231-243.

[Klose 1995] Klose, J., Kobalz, U. : "Two-dimensional electrophoresis of proteins: An updated protocol and implications for a functional analysis of the genome." Electrophoresis 1995: 16: 1034-1059.

[Kool 1997] Kool, M., de-Haas, M., Scheffer, G.L., Scheper, R.J., van-Eijk, M.J. et al.: "Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines." Cancer Res. 1997: 57(16): 3537-3547.

[Khosravi-Far 1995] Khosravi-Far, R. et al.: "Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation." Mol. Cell. Biol. 1995: 15: 6443-6453.

[Kramer 1988] Kramer, R.A., Zakher, J., Kim, G. : "Role of the glutathione redox cycle in acquired and de novo multidrug resistance." Science 1988: 241(4866): 694-697.

[Kule 1994] Kule, C., Ondrejickova, O., Verner, K. : "Doxorubicin, daunorubicin, and mitoxantrone cytotoxicity in yeast." Molecular Pharmacology. 1994: 46(6): 1234-1240.

[Kuss 1994] Kuss, B.J., Deely, R.G., Cole, S.P.C. et al.: "Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications." Lancet 1994: 343: 1531-1534.

[Lage 1998] Lage, H. : "Atypische Multidrug-Resistenz" , Arzneimitteltherapie 1998 im Druck

[Lai 1989] Lai, S.L., Goldstein, L.J., Gottesman, M.M., Pastan, I. et al.: "Mdr1 gene expression in lung cancer." J .Natl. Cancer Inst. 1989: 81(15):1144-1150.

[Lamaze 1996] Lamaze, C. et al.: "Regulation of receptor-mediated endocytosis by Rho and Rac. " Nature 1996: 382: 177-179.

[Laudanna 1996] Laudanna, C. et al.: "Role of Rho in chemoattractant-activated leukocyte adhesion through integrins." Science 1996: 271: 981-983.

[Leffers 1993] Leffers, H., Madsen, P., et al.: "Molecular cloning and expression of the transformation sensitiv epithelial marker stratifin." J. Mol. Biol. 1993: 231: 982-998.

[Leier 1994] Leier, I., Jedlitschky, G., Buchholz, U. et al.: "The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates." J. Biol. Chem. 1994: 269(45): 27807-27810.

[Ling 1974] Ling, V., Thompson, L.H. : "Reduced permeability in CHO cells as a mechanism of resistance to colchicine. " J. Cell. Physiol. 1974: 83(1): 103-116.

[Loe 1996] Loe, D.W., Deeley, R.G., Cole, S.P ".: Biology of the multidrug resistance-associated protein, MRP. " Eur. J. Cancer 1996: 32A(6): 945-957.

[Lown 1985] Lown, J.W., Morgan, A.R., Yen, S.F., Wang, Y.H., Wilson, W.D. : "Characteristics of the binding of the anticancer agents mitoxantrone and ametantrone and related structures to deoxyribonucleic acids." Biochemistry 1985: 24(15): 4028-4035.

[Ma 1987] Ma, D.D.F., Scurr, R.D., Davey, R.A., Mackertich, S.M., Harman, D.H., Dowden, G. et al.: "Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukemia." Lancet 1987: 1: 135-137.

[Ma 1996] Ma, A.S., Ozers, L.J. : "Annexins I and II show differences in subcellular localization and differentiation-related changes in human epidermal keratinocytes. " Arch. Dermatol. Res. 1996: 288(10): 596-603

[Macko 1969] Macko, V., Stegemann, H. : "Mapping of potato proteins by combined electrofocusing and electrophoresis identification of varieties." Hoppe Seylers Z. Physiol. Chem. 1969: 350(7): 917-919.

[Malcom 1994] Malcom, K.C. et al.: "Activation of rat liver phospholipase D by the small GTP-binding protein RhoA. " J. Biol. Chem. 1994: 269: 25951-25954.

[Margolis 1969] Margolis, J., Kenrick, K.G ".: 2-dimensional resolution of plasma proteins by combination of polyacrylamide disc and gradient gel electrophoresis." Nature 1969: 221(185): 1056-1057.

[Maruta 1997] Maruta, H. : "F-actin cappers." Gan To Kagaku Ryoho. 1997: 24(11): 1442-1447.

[Masaki 1996] Masaki, T., Tokuda, M. et al.: "Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma." Hepatology 1996: 24(1): 72-81.

[Masouyé 1997] Masouyé, I., Hagens, G. et al".: Endothelial cells of the human microvasculature express epidermal fatty acid-binding protein." Circ. Res. 1997: 81(3): 297-303.

[Mau 1992] Mau, B.L., Powis, G. : Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin. Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity. Biochem. Pharmacol. 1992: 43(7): 1621-1626.

[Mazzoni 1990] Mazzoni, A., Trave, F., Russo, P. Nicolin, A., Rustum, Y.M ".: Gerneration and characterization of a low-degree drug-resitant human tumor cell line." Oncology 1990: 47: 488-497.

[McGough 1997] McGough, A., Pope, B., Chiu, W., Weeds A ".: Cofilin changes the twist of F-actin: implications for actin filament dynamics and cellular function." J. Cell. Biol. 1997: 138(4): 771-781.

[McGrath 1988] McGrath, T., Center, M.S. : "Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from p-glycoprotein contributes to reduced cellular accumulation of drug." Cancer Res. 1988: 48: 3959-3963.

[Meister 1988] Meister, A. : "Glutathione metabolism and its selective modification." J. Biol. Chem. 1988: 263: 17205-17208.

[Melki 1994] Melki, V., Hullin, F. et al.: "Annexin I as a potential inhibitor of insulin receptor protein tyrosine kinase." Biochem. Biophys. Res. Commun. 1994: 203(2): 813-819.

[Meyer 1993] Meyer, M., Schreck, R. Baeuerle, P.A. : "H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as a secondary antioxidant-responsive factor. " EMBO J. 1993: 12(5): 2005-2015.

[Mirski 1987] Mirski, S.E.L., Gerlach, J.H., Cole, S.P.C. : "Multidrug resistance in a small cell lung cancer cell line selected in adriamycin." Cancer Res. 1987: 47: 2594-2598.

[Moffat 1994] Moffat, G.J., McLaren, A.W., Wolf, C.R. : "Involvement of jun and fos proteins in regulation transcriptional activation of the human pi class glutathione S-transferase gene in multidrug-resistant MCF7 breast cancer cells. " J. Biol. Chem. 1994: 269: 16397-16402.

[Moran 1979] Moran, R.G., Mulkins, M., Heidelberger, C. : "Role of thymidylate synthetase activity in development of methotrexate cytotoxicity" . Proc. Natl. Acad. Sci. USA 1979: 76: 5924-5928.

[Moorman 1996] Moorman, J.P. et al.: "Inactivation of the small GTP binding protein Rho induces multinucleate cell formation and apoptosis in murine T lymphoma EL4." J. Immunol. 1996: 156: 4146-4153.

[Morrow 1990] Morrow, C.S., Cowan, K.H ".: Glutathione S-transferases and drug resistance." Cancer Cells 1990: 2(1): 15-22.

[Muller 1994] Muller, M., Meijer, C., Zaman, G.J.R., Borst, P., Scheper, R.J., Mulder, H. et al.: "Overexpression of the gene encoding multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport." Proc. Natl. Acad. Sci. USA 1994: 91: 13033-13037.

[Naundorf 1995] Naundorf, H., Zschiesche, W. et al.: "Influence of liposomes rich in unsaturated or saturated fatty acids on the growth of human xenotransplanted mammary carcinomas and on the levels of heart type fatty acid binding protein." In Vivo 1995: 9(3): 247-251.

[Nebl 1996] Nebl, G., Meuer, S.C., Samstag,Y. : "Dephosphorylation of serine 3 regulates nuclear translocation of cofilin" . J. Biol. Chem. 1996: 271(42): 26276-26280.

[Neuhoff 1988] Neuhoff, V., Arold, N., Taube, D., Ehrhardt, W. : "Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250." Electrophoresis 1988: 9(6): 255-262.

[Nooter 1996] Nooter, K., Bosman, F.T., Burger, H. et al".: Expression of the multidrug resitance-associated protein (MRP) gene in primary non-small-cell lung canmcer." Ann. Oncol. 1996: 7: 75-81.

[Nunberg 1978] Nunberg, J.H, Kaufman, R.J. et al".: Amplified dihydrofolat reductase genes are localized to a homologously staining region of a single chromosome in a methotrexate -resistant Chinese hamster ovary cell line. " Proc. Natl. Acad. Sci. USA 1978: 75(11): 5553-5556.

[Oda 1996] Oda, Y., Schneider-Stock, R., Rys, J., Gruchala, A. et al".: Expression of multidrug-resistance-associated protein gene in human soft-tissue sarcomas." J. Cancer Res. Clin. Oncol. 1996: 122(3): 161-165.

[O'Farrell 1975] O'Farrell, P.H ".: High resolution two-dimensional electrophoresis of proteins." J. Biol. Chem. 1975: 250(10): 4007-21.

[Okamoto 1996] Okamoto, K., Toyokuni, S. et al.: "Overexpression of human muT homologue gene messenger RNA in renal-cell-carcinoma: evidence of persistent oxidative stress in cancer. " Int. J. Cancer 1996: 65: 437-441.

[Olson 1995] Olson, M.F. et al".: An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1." Science 1995: 269: 1270-1272.

[Ota 1995] Ota, E., Abe, Y., Oshika, Y., Ozeki, Y., Iwasaki, M., Inoue, H. et-al.: "Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer." Br. J. Cancer 1995: 72(3): 550-554.

[Palmgren 1998] Palmgren, M.G., Fuglsang, A.T., Jahn, T ".: Deciphering the role of 14-3-3 proteins." Exp. Biol. Online 1998: 3: 4.

[Papadopoulou 1994] Papadopoulou, B., Roy, G., Dey, S., Rosen, B.P., Ouellette, M ".: Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance." J. Biol. Chem. 1994: 269(16): 11980-11986.

[Pastan 1987] Pastan, I., Gottesman, M. : "Multiple drug resistance in human cancer." N. Engl. J. Med. 1987: 316: 1388-1393.

[Paulusma 1996] Paulusma, C.C., Bosma, P.J., Zaman, G.J., Bakker, C.T., Otter, M. et al.: "Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. " Science 1996: 271(5252): 1126-1128.

[Pegg 1990] Pegg, A.E. : "Mammalian O6-alkylguanin-DNA-alkyltransferase: regulation and importance in response to alkylating carcinogenic and therpeutic agents. " Cancer Res. 1990: 50: 6119-6129.

[Perez 1990] Perez, R.P., Hamilton, T.C., Ozols, R.F. : "Resistance to alkylating agents and cisplatin: Insights from ovarian carcinoma model systems." Pharmacol. Ther. 1990: 48(1): 19-27.

[Peters 1992] Peters, W.H., Roelofs, H.M. : "Biochemical characterization of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells: a possible role for glutathion S-transferases." Cancer Res. 1992: 52(7): 1886-1890.

[Powis 1998] Powis, G., Kirkpatrick, D.L. et al.: "Thioredoxin redox control of cell growth and death and the effects of inhibitors." Chem. Biol. Interact. 1998: 111-112: 23-34.

[Pusztai 1993] Pusztai, L., Lewis, D.E., Lorenzen, J. : "Growth factors: regulation of normal and neoplastic growth." J. Path. 1993: 169: 191-201.

[Rabilloud 1994] Rabilloud, T., Valette, C. et al".: Sample application by in-gel rehydration improves the resolution of two-dimensional electrophoresis with immobilized pH gradients in first dimension." Electrophoresis 1994: 15: 1-7.

[Raderer 1993] Raderer, M., Scheithauer, W ".: Clinical trials of agents that reverse multidrug resitance." Cancer 1993: 72: 3553-3563.

[Rappa 1997] Rappa, G., Loico A., Flavell R.A., Sartorelli A.C ".: Evidence that the multidrug resistance protein (MRP) functions as aco-transporter of glutathione and natural product toxins." Cancer Res. 1997: 57: 5232-5237.

[Ray 1994] Ray, M.E., Guan, X.Y., Slovak, M.L., Trent, J.M., Meltzer, P.S ".: Rapid detection, cloning and molecular cytogenteic characterisation of sequences from an MRP-encoding amplicon by chromosome microdissection. " Br. J. Cancer 1994: 70: 85-90.

[Rhoads 1946] Rhoads, C.P. : "Nitrogen mustards in treatment of neoplastic disease." JAMA 1946: 21: 656-658.

[Righetti 1983] Rigetti, P.G. : "Isoelectric focusing: Therory, methodology and applications." Amsterdam, NY, Oxford, Elsevier 1983.

[Righetti 1989] Righetti, P.G., Gianazza, E., Gelfi, C., Chiari, M., Sinha, P ".: Isoelectric focusing in immobilized pH Gradients. " Analytical Chemistry 1989: 61: 1602-1611.

[Riordan 1985] Riordan, J.R., Ling, V. : "Genetic and biochemical characterization of multidrug resistance. " Pharmacol. Ther. 1985: 28(1): 51-75.

[Riordan 1989] Riordan, J.R., Rommens, J.M., Kerem, B., Alon, N., Rozmahel, R. et al.: "Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA." Science 1989: 245(4922): 1066-1073.

[Ro 1990] Ro, J., Sakin, A., Ro, J.Y ".: Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer." Hum. Pathol. 1990: 21: 787-791.

[Rome 1995] Rome, L.H. : "Multidrug resitance: Locked in the vault? " Nat. Med. 1995: 1(6): 527.

[Ross 1979a] Ross, W.E, Zwelling, L.A. et al.: "Relationship between cytotoxicity and DNA strand breakage produced by adriamycin and other intercalating agents" . Int. J. of Radiation Onc., Biolg.-Physics 1979: 5: 1221-1224.

[Ross 1979b] Ross, W.E, Glaubiger, D., Kohn, K.W. :" Qualitative and quantitative aspects of intercalator-induced DNA strand breaks." Biochemica and Biophysica Acta 1979: 562: 41-50.

[Rothenberg 1989] Rothenberg, M.L., Mickley, L.A., Cole, D.E. : "Expression of the mdr-1/P-170 gene in patients with acute leukemia." Blood 1989: 74: 1388-1395.

[Rothenberg 1989] Rothenberg, M.L., Mickley, L.A., Cole, D.E., Balis, ,F.M. et al.: "Expression of the mdr-1-p-170 gene in patients with acute lymphoblastic leukemia." Blood 1989: 74(4): 1388-1395.

[Rutherford 1993] Rutherford, A.V., Willingham, M.C ".: Ultrastructurs localization of daunomycin in multidrug-resitant cultured cells with modulation of multidrug transporter" . J. Histochem. Cytochem. 1993: 41: 1573-1577.

[Saitoh 1998] Saitoh, M., Nishitoh, H. et al.: "Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1." EMBO J. 1998: 17(9): 2596-2606.

[Sakamoto 1996] Sakamoto, T., Repasky, W.T. et al.: "Modulation of cell death pathways to apoptosis and necrosis of H2O2-treated rat thymocytes by lipocortin I. " Biochem. Biophys. Res. Commun. 1996: 220(3): 643-647.

[Samstag 1994] Samstag, Y., Eckerskorn, C. et al.: "Costimulatory signals for human T-cell activation induce nuclear translocation of pp19/cofilin." Proc. Natl. Acad. Sci. USA. 1994: 91(10): 4494-4498.

[Samstag 1996] Samstag, Y., Dreizler, E.M. et al.: "Inhibition of constitutive serine phosphatase activity in T lymphoma cells results in phosphorylation of pp19/cofilin and induces apoptosis." J. Immunol. 1996: 156(11): 4167-4173.

[Sasaki 1998] Sasaki, T., Takai, Y. : "The Rho small G protein family-Rho GDI system as a temporal and spatial determinant for cytoskeletal control." Biochem. Biophys. Res. Commun. 1998: 245(3): 641-645.

[Sato 1990] Sato, H., Gottesman, M.M., Goldstein, L.J., Pastan, I., Block, A.M., Sandberg, A.A., Preisler, H.D. : "Expression of the multidrug resistance gene in myeloid leukemias." Leuk. Res. 1990: 14(1): 11-21.

[Scanlon 1989] Scanlon, K.J., Kashani-Sabet, M., Miyachi, H., Sowers, L.C., Rossi, J .: "Molecular basis of cisplatin resistance in human carcinomas: model systems and patients." Cancer Res. 1989: 9: 1301-1312.

[Schadendorf 1995] Schadendorf, D., Makki, A., Stahr, C., van-Dyck, A., Wanner, R., Scheffer, G.L. et al.: "Membrane transport proteins associated with drug resistance expressed in human melanoma." Am. J. Pathol. 1995: 147(6): 1545-1552.

[Scheffer 1995] Scheffer, G.L., Wijngaard, P.L., Flens, M.J., Izquierdo, M.A., Slovak, M.L., Pinedo, H.M. et al.: "The drug resistance-related protein LRP is the human major vault protein." Nat. Med. 1995: 1(6): 578-582.

[Schenk 1996] Schenk, H., Vogt, M. et al.: "Thioredoxin as a potent costimulus of cytokine expression. " J. Immunol. 1996: 156(2): 765-771.

[Scheper 1993] Scheper, R.J. et al".: Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance." Cancer Res. 1993: 53: 1475-1479.

[Schilisky 1981] Schilisky, R.L., Bailey, B.D., Chabner, B.A. : "Characteristics of membrane transport of methotrexate by cultured human breast cancer cells." Bioch. Pharm. 1981: 30: 1537-1542.

[Schneider 1989] Schneider, J., Bak, M., Efferth, T. : "P-glycoprotein expression in treated and untreated human breast canver." Br. J. Cancer 1989: 60: 815-818.

[Schuurhuis 1991] Schuurhuis, G.J. et al.: "Early multidrug resistance, defined by changes in intracellular doxirubicin distribution, indipendent of P-glycoprotein." Br. J. Cancer 1991: 64: 857-861.

[Seidel 1995] Seidel, A., Hasmann, M., Loser, R., Bunge, A., Schaefer, B., Herzig, I. et al.: "Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multidrug-resistant gastric carcinoma EPG85-257 cells." Virchows Arch. 1995: 426(3): 249-256.

[Shapiro 1967] Shapiro, A.L., Vinuela, E., Maizel, J.V. Jr. : "Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels" . Biochem. Biophys. Res. Commun. 1967: 28(5): 815-820.

[Shen 1986] Shen, D.W., Fojo, A., Chin, J.E. : "Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification." Science 1986: 232: 643-645.

[Simon 1994] Simon, S.M., Schindler, M ".: Cell biological mechanisms of multidrug resistance in tumors." Proc. Natl. Acad. Sci. USA 1994: 91(9): 3497-3504.

[Simonsen 1983] Simonsen, C.C., Levinson, A.D. : "Isolation and expression of an altered mouse dihydrofolate reductase cDNA." Proc. Natl. Acad. Sci. USA 1983: 80(9): 2495-2499.

[Sinha 1987] Sinha, P.K., Righetti, P.G. : "Isoelectric focusing of basic proteases in immobilized pH gradients." J. Biochem. Biophys. Methods 1987: 15(3-4): 199-206.

[Sirotnak 1981] Sirotnak, F.M., Moccio, D.M. et al".: Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo." Cancer Res. 1981: 41: 4447-4452.

[Sirotnak 1987] Sirotnak, F.M. : "Determinants of resistance to antifolates: biochemical phenotypes, their frequency of occurrence and circumvention." NCI Monogr. 1987: 5: 27-37.

[Sklar 1991] Sklar, M.D., Prochownik, E.V. : "Modulation of cisplatinum resistance in friend erythroleukemia cells by c-myc." Cancer Res. 1991: 51: 2118-2123.

[Slovak 1993] Slovak, M.L., Ho, J.P., Bhardwaj, G., Kurz, E.U. et al".: Localisation of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines." Cancer Res. 1993: 53: 3221-3225.

[Smith 1990] Smith, P.J., Morgan, S.A. et al.: "Mitoxantrone-DNA binding and the induction of topoisomerase II associated DNA damage in multi-drug resistant small cell lung cancer cells." Biochem. Pharmacol. 1990: 40(9): 2069-2078.

[Soldan 1996] Soldan, M., Netter, K.J., Maser, E ".: Induction od daunorubicin carbonyl reducing enzymes by daunorubicin in sensitive and resistant pancreas carcinoma cells. " Biochem. Pharmacology 1996: 51/2: 117-123.

[Sorof 1994] Sorof, S ".: Modulation of mitogenesis by liver fatty acid binding protein. " Cancer Metastasis Rev. 1994: 13(3-4): 317-336.

[Stutts 1992] Stutts, M.J., Chinet, T.C., Mason, S.J., Fullton, J.M. et al".: Regulation of Cl- channels in normal and cystic fibrosis airway epithelial cells by extracellular ATP. " Proc. Natl. Acad. Sci. USA 1992: 89(5): 1621-1625.

[Szczypka 1994] Szczypka, M.S., Wemmie, J.A., Moye-Rowley, W.S., Thiele, D.J. : "A yeast metal resistance protein similar to human cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein." J. Biol. Chem. 1994: 269(36): 22853-22857.

[Takahashi 1997] Takahashi, K., Sasaki, T. et al.: "Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein." J. Biol. Chem. 1997: 272(37): 23371-23375.

[Takeuchi 1992] Takeuchi, N., Nakamura, T et al.: "Inhibitory effect of mitoxantron on activity of protein kinase C and growth of HL60 cells. " J. Biochem. Tokyo 1992: 112(6): 762-767.

[Takikawa 1992] Takikawa, H., Arai, S., Yamanaka, M. : "Binding of bile acids, organic anions, and ftty acids by bovine intestinal Z protein." Arch. Biochem. Biophys . 1992: 292(1): 151-155.

[Taniguchi 1996] Taniguchi K., Wada, M., Kohno, K., Nakamura, T. et al".: A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation." Cancer Res. 1996: 56(18): 4124-4129.

[Tew 1994] Tew K.D. : "Glutathione-associated enzymes in anticancer drug resistance. " Cancer Res. 1994: 54(16): 4313-4320.

[Tewey 1984] Tewey, K.M., Chen, G.L. et al.: "Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA Topoisomerase II." J. Biolg. Chem. 1984: 259: 9182-9187.

[Thomas 1996] Thomas, A., El Rouby, S. et al.: "Drug-induced apoptosis in B-cell chronic lymphocytic leukenia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance." Oncogene 1996: 12: 1055-1062

[Tsai 1993] Tsai, C.M., Chang, K.T. et al.: "Correlation of intrinsic chemoresistance of non-small cell lung cancer cell lines with Her-2/neu gene expression but not with ras gene mutations." J. Natl. Cancer. Inst. 1993: 85: 897-901.

[Ueda 1986] Ueda, K., Cornwell, M.M., Gottesman, M.M., Pastan, I., Roninson, I.B. et al.: "The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein." Biochem. Biophys. Res. Commun. 1986: 141(3): 956-962.

[Van der Bliek 1988] Van der Bliek, A.M., Baas, F., Van der Velde-Koerts, T. : "Genes amplified and overexpressed in human multidrug resistant cell lines." Cancer Res. 1988: 48: 5927-5932.

[Van der Bliek 1989] Van der Bliek, A.M., Borst, P. : "Multi-drug resistance." Adv. Cancer Res. 1989: 52: 165-203.

[Velculescu 1996] Velculescu, V.E., El-Deiry, W.S. : "Biological and clinical importance of the p53 tumor suppressor gene." Clin. Chem. 1996: 42: 858-868.

[Vellucci 1995] Vellucci,V.F., Germino,F.J., Reiss, M ".: Cloning of putative growth regulatory genes from primary human keratinocytes by subtractive hybridization." Gene 1995: 166(2): 213-220.

[Waldman 1996] Waldman, T., Lengauer, C. et al.: "Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21." Nature 1996: 381: 713-716.

[White 1975] White, J.C., Loftfield, S., Goldman, I.D. : "The mechanism of action of methotrexate. III: Requirement of free intracellular methotrexate for maximal suppression of [14C] formate incorporation into nucleic acids and proteins." Molec. Pharma. 1975: 11: 287-297.

[Wirth 1992] Wirth, P.J., Luo, L.D., Fujimoto, Y., Bisgaard, H.C. : "Two-dimensional electrophoretic analysis of transformation-sensitive polypeptides during chemically, spontaneously, and oncogene-induced transformation of rat liver epithelial cells." Electrophoresis 1992: 13(5): 305-320.

[Wolf 1986] Wolf, C.R., Macpherson, J.S., Smyth, J.F. : "Evidence for the metabolism of mitozantrone by microsomal glutathione transferases and 3-methylcholanthrene-inducible glucuronosyl transferases" . Biochem-Pharmacol. 1986: 35(9): 1577-1581

[Yahara 1996] Yahara, I., Aizawa, H. et al.: "A role of cofilin/destrin in reorganization of actin cytoskeleton in response to stresses and cell stimuli. " Cell. Struct. Funct. 1996: 21(5): 421-424.

[Yamada 1997] Yamada, M., Tomida, A. et al".: Overexpression of thioredoxin does not confer resistance to cisplatin in transfected human ovarian and colon cancer cell lines." Cancer Chemother. Pharmacol. 1997: 40(1): 31-37.

[Yarosh 1983] Yarosh, D., Foote, R., Mitra, S. : "Repair of D6-methylguamine in DNA by demethylation is lacking in MER minus human tumour cell strains. " Carcinogesis 1983: 4: 199-205.

[Zaman 1994] Zaman, G.J., Flens, M.J., van-Leusden, M.R. et al.: "The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump." Proc. Natl. Acad. Sci.USA 1994: 91(19): 8822-8826.

[Zeng 1994] Zeng, Y. et al".: Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85." J. Biol. Chem. 1994: 269: 18727-18730.

[Zhu 1994] Zhu, Q., Center, M.S. : "Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cell isolated for resistance to adriamycin" . Cancer Res. 1994: 54: 4488-4492.

[Titelseite] [1] [2] [3] [4] [5] [6] [Abkürzungsverzeichnis] [Bibliographie] [Lebenslauf] [Selbständigkeitserklärung]

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.

DiML DTD Version 2.0
Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML - Version erstellt am:
Tue Apr 4 17:02:28 2000